A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib
about
Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancerA phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumorsOver-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinomaEndoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse modelsInduction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine.Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.De Novo Emergence of Mesenchymal Stem-Like CD105+ Cancer Cells by Cytotoxic Agents in Human Hepatocellular Carcinoma.Quantitative Methods in Abdominal MRI: Perfusion Imaging.Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody.ALK1 signaling in development and disease: new paradigms.Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection.Recent advances in non-invasive magnetic resonance imaging assessment of hepatocellular carcinoma.Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma
P2860
Q28079205-917E6ED4-2620-44A9-8676-C650BE0BB3DBQ33431483-5B70476F-1089-4D6B-8AEA-31D01E6AB4B2Q33618665-E1B6A3D2-1964-4F2C-A6B7-2DD29DA989C9Q33640207-80660FCB-8E28-4843-9A64-6F60AC36F4F0Q33709802-4B4B0A9F-F898-4165-94E5-22F68DFC131EQ38754448-E6C9C872-4F2D-4409-97A0-C37B8107214DQ38969367-F1F70F9A-78C8-4CDB-905D-737BEF68EAAEQ47412444-B27752F6-24CB-4177-9F86-846EE36A3B3CQ47777542-4CE926BF-33C0-41F3-A325-2B130C4C7CF3Q47856805-C695E240-4862-4E2F-AD38-B523DE11F657Q50041876-66A32779-5AE6-4D93-BDC8-1FABEA639B3DQ55227929-58517E21-16AF-4A76-B3A9-7B1CC49A7E66Q57646291-4467BBC9-AAA2-4ACF-8E24-43A7D3480D80
P2860
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A phase II study of TRC105 in ...... o have progressed on sorafenib
@ast
A phase II study of TRC105 in ...... o have progressed on sorafenib
@en
type
label
A phase II study of TRC105 in ...... o have progressed on sorafenib
@ast
A phase II study of TRC105 in ...... o have progressed on sorafenib
@en
prefLabel
A phase II study of TRC105 in ...... o have progressed on sorafenib
@ast
A phase II study of TRC105 in ...... o have progressed on sorafenib
@en
P2093
P2860
P356
P1476
A phase II study of TRC105 in ...... o have progressed on sorafenib
@en
P2093
A M Venkatesan
D E Kleiner
K C Bollen
O V Makarova-Rusher
P2860
P304
P356
10.1177/2050640615583587
P577
2015-10-01T00:00:00Z